» Authors » Blanca Estela Perez-Aldana

Blanca Estela Perez-Aldana

Explore the profile of Blanca Estela Perez-Aldana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 9
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lozano-Tovar S, Rodriguez-Agudelo Y, Davila-Ortiz de Montellano D, Perez-Aldana B, Ortega-Vazquez A, Monroy-Jaramillo N
Int J Environ Res Public Health . 2023 Mar; 20(5). PMID: 36901420
Alzheimer's disease (AD) is characterized by the presence of neuropsychiatric or behavioral and psychological symptoms of dementia (BPSD). BPSD have been associated with the allele, which is also the major...
2.
Perez-Aldana B, Martinez-Magana J, Mayen-Lobo Y, Davila-Ortiz de Montellano D, Avina-Cervantes C, Ortega-Vazquez A, et al.
Front Psychiatry . 2022 Jun; 13:870656. PMID: 35664466
Long-term studies have shown significantly lower mortality rates in patients with continuous clozapine (CLZ) treatment than other antipsychotics. We aimed to evaluate epigenetic age and DNA methylome differences between CLZ-treated...
3.
Monroy-Jaramillo N, Martinez-Magana J, Perez-Aldana B, Ortega-Vazquez A, Montalvo-Ortiz J, Lopez-Lopez M
Pharmacogenomics . 2022 Mar; 23(6):371-392. PMID: 35311547
Clozapine (CLZ) is an atypical antipsychotic reserved for patients with refractory psychosis, but it is associated with a significant risk of severe adverse reactions (ADRs) that are potentiated with the...
4.
Mayen-Lobo Y, Martinez-Magana J, Perez-Aldana B, Ortega-Vazquez A, Genis-Mendoza A, Davila-Ortiz de Montellano D, et al.
Pharmaceuticals (Basel) . 2021 Feb; 14(2). PMID: 33557049
Clozapine (CLZ) is the only antipsychotic drug that has been proven to be effective in patients with refractory psychosis, but it has also been proposed as an effective mood stabilizer;...